Reliable drug delivery to the inner ear is still an unmet clinical need, due to the blood cochlear barrier, which effectively protects this highly sensitive organ. To overcome this hurdle, miniaturized, biodegradable implants were prepared (0.3 mm in diameter), which can be administered into the cochlea via a tiny hole drilled into the round window....
No actionable clinical change yet — this is preclinical/early-stage research; findings may inform future inner ear drug delivery strategies but are not ready for clinical application.
Controlled multi-drug delivery directly to the cochlea could eventually transform treatment of conditions like sudden hearing loss, Meniere's disease, and ototoxicity (medication-related hearing damage) by bypassing the blood-cochlear barrier.
- 01PLGA (a biodegradable plastic used in medical implants) implants were designed for placement inside the cochlea (inner ear).
- 02The implants can release multiple drugs simultaneously in a controlled manner.
- 03The approach targets the blood-cochlear barrier, which normally prevents drugs from reaching the inner ear.
- 04This is a laboratory/preclinical study; human application is not yet established.
- 05Multi-drug delivery could open avenues for combination therapies for inner ear disorders.
Intracochlear PLGA implants can achieve simultaneous controlled release of multiple drugs.
studypartially supportedPLGA implants can overcome the blood-cochlear barrier for inner ear drug delivery.
studypartially supported- PMID
- 42070660
- DOI
- 10.1016/j.jconrel.2026.114977.
- Journal
- Journal of Controlled Release
- Publication type
- research_article
- Evidence level
- 4
- Population
- In vitro / animal model (cochlear implant delivery system)
- Intervention
- Intracochlear PLGA implants for multi-drug controlled release
Primary outcomes
Simultaneous controlled release of multiple drugs from PLGA implants; Overcoming the blood-cochlear barrier for inner ear drug delivery